127 related articles for article (PubMed ID: 9372096)
1. Prognostic markers in acute leukemia.
Leith CP; Willman CL
Curr Opin Hematol; 1996 Jul; 3(4):329-34. PubMed ID: 9372096
[TBL] [Abstract][Full Text] [Related]
2. The prognostic significance of the expression and function of multidrug resistance transporter proteins in acute myeloid leukemia: studies of the Southwest Oncology Group Leukemia Research Program.
Willman CL
Semin Hematol; 1997 Oct; 34(4 Suppl 5):25-33. PubMed ID: 9408958
[TBL] [Abstract][Full Text] [Related]
3. Driving Toward Precision Medicine for Acute Leukemias: Are We There Yet?
Chung C; Ma H
Pharmacotherapy; 2017 Sep; 37(9):1052-1072. PubMed ID: 28654205
[TBL] [Abstract][Full Text] [Related]
4. AC133 antigen as a prognostic factor in acute leukemia.
Lee ST; Jang JH; Min YH; Hahn JS; Ko YW
Leuk Res; 2001 Sep; 25(9):757-67. PubMed ID: 11489469
[TBL] [Abstract][Full Text] [Related]
5. Drug resistance mechanisms in acute leukemia.
Chauncey TR
Curr Opin Oncol; 2001 Jan; 13(1):21-6. PubMed ID: 11148681
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of Bcl-XL gene expression for remission induction is influenced by cytogenetics in adult acute myeloid leukemia.
Schaich M; Illmer T; Seitz G; Mohr B; Schäkel U; Beck JF; Ehninger G
Haematologica; 2001 May; 86(5):470-7. PubMed ID: 11410409
[TBL] [Abstract][Full Text] [Related]
7. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells.
Drexler HG
Leukemia; 1998 Jun; 12(6):845-59. PubMed ID: 9639410
[TBL] [Abstract][Full Text] [Related]
8. Multidrug resistance in acute leukemia: a conserved physiologic function.
List AF; Spier CM
Leuk Lymphoma; 1992 Sep; 8(1-2):9-14. PubMed ID: 1283551
[TBL] [Abstract][Full Text] [Related]
9. P-glycoprotein and multidrug resistance associated protein-1 activity in 132 acute myeloid leukemias according to FAB subtypes and cytogenetics risk groups.
Legrand O; Zompi S; Perrot JY; Faussat AM; Benderra Z; Chaoui D; Marie JP
Haematologica; 2004 Jan; 89(1):34-41. PubMed ID: 14754604
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.
Wuchter C; Leonid K; Ruppert V; Schrappe M; Büchner T; Schoch C; Haferlach T; Harbott J; Ratei R; Dörken B; Ludwig WD
Haematologica; 2000 Jul; 85(7):711-21. PubMed ID: 10897123
[TBL] [Abstract][Full Text] [Related]
11. Characterization of leukemias with ETV6-ABL1 fusion.
Zaliova M; Moorman AV; Cazzaniga G; Stanulla M; Harvey RC; Roberts KG; Heatley SL; Loh ML; Konopleva M; Chen IM; Zimmermannova O; Schwab C; Smith O; Mozziconacci MJ; Chabannon C; Kim M; Frederik Falkenburg JH; Norton A; Marshall K; Haas OA; Starkova J; Stuchly J; Hunger SP; White D; Mullighan CG; Willman CL; Stary J; Trka J; Zuna J
Haematologica; 2016 Sep; 101(9):1082-93. PubMed ID: 27229714
[TBL] [Abstract][Full Text] [Related]
12. Adult biphenotypic acute leukaemia: an entity with poor prognosis which is related to unfavourable cytogenetics and P-glycoprotein over-expression.
Legrand O; Perrot JY; Simonin G; Baudard M; Cadiou M; Blanc C; Ramond S; Viguié F; Marie JP; Zittoun R
Br J Haematol; 1998 Jan; 100(1):147-55. PubMed ID: 9450804
[TBL] [Abstract][Full Text] [Related]
13. New prognostic markers in acute myeloid leukemia: perspective from the clinic.
Foran JM
Hematology Am Soc Hematol Educ Program; 2010; 2010():47-55. PubMed ID: 21239770
[TBL] [Abstract][Full Text] [Related]
14. Influence of new molecular prognostic markers in patients with karyotypically normal acute myeloid leukemia: recent advances.
Mrózek K; Döhner H; Bloomfield CD
Curr Opin Hematol; 2007 Mar; 14(2):106-14. PubMed ID: 17255787
[TBL] [Abstract][Full Text] [Related]
15. Identification of a panel of ten cell surface protein antigens associated with immunotargeting of leukemias and lymphomas by peripheral blood gammadelta T cells.
Gomes AQ; Correia DV; Grosso AR; Lança T; Ferreira C; Lacerda JF; Barata JT; Silva MG; Silva-Santos B
Haematologica; 2010 Aug; 95(8):1397-404. PubMed ID: 20220060
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in pediatric acute lymphoblastic and myeloid leukemia.
Ravindranath Y
Curr Opin Oncol; 2003 Jan; 15(1):23-35. PubMed ID: 12490758
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetics of hybrid acute leukemias.
Cuneo A; Boogaerts M; Ferrant A; Michaux JL; Bosly A; Louwagie A; Van den Berghe H; Balsamo R; Roberti G; Bardi A
Leuk Lymphoma; 1995; 18 Suppl 1():19-23. PubMed ID: 7496350
[TBL] [Abstract][Full Text] [Related]
18. MDR1/P-GP expression as a prognostic factor in acute leukemias.
Marie JP; Legrand O
Adv Exp Med Biol; 1999; 457():1-9. PubMed ID: 10500774
[TBL] [Abstract][Full Text] [Related]
19. Therapy of acute myeloid leukemia: towards a patient-oriented, risk-adapted approach.
Mandelli F; Petti MC; Lo Coco F
Haematologica; 1998 Nov; 83(11):1015-23. PubMed ID: 9864924
[TBL] [Abstract][Full Text] [Related]
20. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
